Did you know? You can suggest edits to improve this peptide information.
Overview
What is HGH (Somatropin)?
Human Growth Hormone (HGH), also known as somatropin or somatotropin, is a 191 amino acid single-chain polypeptide hormone naturally produced by the anterior pituitary gland. Recombinant HGH (rhGH/somatropin) is bioidentical to endogenous growth hormone and is FDA-approved for growth hormone deficiency in children and adults, as well as several other conditions. The '191aa' designation refers to its complete 191 amino acid structure, distinguishing it from older 192aa formulations. HGH regulates growth, metabolism, body composition, and numerous physiological processes through direct actions and via stimulating IGF-1 production.
Key Benefits
Improved body composition (increased lean mass, decreased fat mass), enhanced bone mineral density, improved lipid profile, increased exercise capacity, better quality of life and mood, skin and hair improvements, enhanced recovery and healing
Mechanism of Action
HGH binds to GH receptors on target tissues, triggering JAK2-STAT5 signaling pathway. Direct effects include lipolysis, protein synthesis stimulation, and metabolic regulation. Indirect effects occur via IGF-1 stimulation in liver and peripheral tissues, promoting growth, cell proliferation, and anabolism. Half-life: ~3 hours subcutaneously; peak levels 3-5 hours post-injection.
Molecular Information
Weight
22,124 Da (22 kDa)
Length
191 amino acids
Type
Single-chain polypeptide with two disulfide bridges
Amino Acid Sequence:
191 amino acid single-chain protein with 4 cysteine residues forming 2 intrachain disulfide bonds. Identical to endogenous pituitary-derived hGH
* Recombinant form (somatropin) is bioidentical to natural human growth hormone. Produced via E. coli recombinant DNA technology
Research Indications
Pediatric Growth Hormone Deficiency
FDA-approved for children with GHD, including idiopathic and organic causes. Also approved for Turner syndrome, Prader-Willi syndrome, SGA, Noonan syndrome, SHOX deficiency, and chronic renal insufficiency
Adult Growth Hormone Deficiency
FDA-approved for adults with GHD from childhood-onset or adult-onset causes including pituitary tumors, surgery, radiation, or trauma. Requires biochemical confirmation
HIV-Associated Wasting
FDA-approved indication for treatment of HIV-associated wasting/cachexia to increase lean body mass and body weight
Research Protocols
Disclaimer
These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing
Morning fasted injection maximizes fat-burning potential. Evening injection mimics natural nocturnal GH pulse. At doses >4 IU, splitting into AM and PM injections can reduce side effects and improve utilization.
Peptide Interactions
How to Reconstitute
Important
Always use bacteriostatic water (BAC). Sterile technique is essential.
Remove HGH vial from refrigerator and allow to reach room temperature (15-20 minutes)
Clean the rubber stopper of both HGH vial and BAC water with alcohol swab
Determine reconstitution volume - common: 1 mL BAC water per 10 IU vial (each 0.1 mL = 1 IU)
Draw bacteriostatic water into syringe slowly, removing all air bubbles
Insert needle into HGH vial at angle, aiming stream at vial wall - NOT directly on powder
Inject BAC water slowly down the inside wall of the vial - drop by drop
Remove needle and gently swirl vial in circular motion - NEVER SHAKE
Allow to sit if any cloudiness, then swirl again until completely clear
Solution should be crystal clear - discard if cloudy or contains particles
Label vial with reconstitution date and concentration
Store in refrigerator at 2-8°C, use within 14-28 days depending on product
Quality Indicators
White lyophilized powder/cake
Should appear as white to off-white powder or solid cake - not liquid or collapsed
Crystal clear reconstituted solution
After proper reconstitution, solution must be completely clear and colorless with no particles
Vacuum intact in sealed vial
Properly sealed vials should show resistance when inserting needle due to vacuum
Pharmaceutical grade with COA
Pharmaceutical brands (Genotropin, Norditropin, Humatrope) preferred; research grade should have certificate of analysis
Generic/underground lab products
Vary significantly in quality and potency. Third-party testing recommended. Common counterfeits exist
Cloudy, discolored, or particles visible
Any cloudiness, yellow/brown color, or floating particles indicates degradation - do not use
Powder appears melted or stuck to vial
Indicates improper storage/temperature exposure - peptide likely degraded
What to Expect
- Week 1-2: Improved sleep quality, increased energy, possible water retention and joint stiffness
- Week 2-4: Enhanced recovery from exercise, skin beginning to improve, possible numbness/tingling in hands (carpal tunnel symptoms)
- Month 1-2: Noticeable fat loss beginning (especially abdominal), improved skin elasticity and texture
- Month 2-3: Continued fat loss, lean mass improvements, hair/nail growth, reduced recovery time
- Month 3-6: Significant body composition changes, improved bone density markers, sustained energy and well-being
- Long-term: Maintained benefits with ongoing use; effects diminish over weeks-months after discontinuation
- Note: Side effects (water retention, joint pain, carpal tunnel) often peak in first 4-8 weeks then improve
Side Effects & Safety
- FDA-approved only for specific medical conditions - off-label use carries legal and health risks
- Start with low dose and increase gradually to minimize side effects (fluid retention, joint pain)
- Monitor blood glucose - HGH causes insulin resistance and can unmask or worsen diabetes
- Monitor thyroid function - can unmask hypothyroidism; may require T4 supplementation
- Contraindicated with active cancer - GH may accelerate tumor growth
- Contraindicated in acute critical illness - increased mortality shown in ICU patients
- Do not use for growth promotion in children with closed epiphyses
- Carpal tunnel syndrome common - usually resolves with dose reduction or time
- Long-term high-dose use associated with acromegaly-like side effects (enlarged features, organ growth)
- Not recommended during pregnancy or breastfeeding
References
KIMS Long-Term Safety Study (2022)
Largest long-term safety study of GH replacement showing de novo cancer incidence comparable to general population (SIR 0.92). Supports safety of long-term GH replacement in routine clinical practice.
View Study (opens in new tab) →Effects on Morbidity - Systematic Review (2014)
Positive effects demonstrated on cardiovascular surrogate markers and bone metabolism. Suggests potential positive effect on CVD and fracture risk, though study design limitations noted.
View Study (opens in new tab) →Adult GHD Clinical Syndrome Characterization (2011)
Established the syndrome of adult GH deficiency: decreased exercise tolerance, reduced mood/well-being, increased central adiposity, hyperlipidemia, reduced bone density, and atherogenesis predisposition.
View Study (opens in new tab) →Quick Start Guide
Community Poll
Question 1 of 10
What is your experience with this compound?
Poll Results
Loading results...
Community Insights
Self-reported by PepPedia users. Not clinical evidence. Health changes reflect all users, including those taking multiple compounds.
Was this helpful?
Your feedback helps us improve PepPedia